Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAn update to the site revision indicator from v3.4.1 to v3.4.2 was applied; no changes to study content, eligibility criteria, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now includes a dedicated Locations section listing study sites by state (California, Florida, Illinois, Massachusetts, Missouri, New York, North Carolina, Ohio, Pennsylvania, Virginia, Wisconsin) and the revision metadata was updated to v3.3.3, replacing the previous state-specific location headings.SummaryDifference1%

- Check91 days agoChange DetectedPublications section text now clarifies that publications are automatically filled from PubMed and may not all relate to the study. The revision label has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check99 days agoChange DetectedThe funding/operating status banner was removed from the page. The core study details and eligibility information remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.